Clinical Trial Update: ATAGLU: Study of Glucose Metabolism in HIV Positive Patients That Switch From Another Protease Inhibitor to Atazanavir [NA]

View source ↗

Summary

This entry describes a clinical trial evaluating glucose metabolism in HIV-positive patients who switch from another protease inhibitor to atazanavir.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• REYATAZ (atazanavir)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: HIV | NA | Status: UNKNOWN